ImageneBio IMA Ratios (2020-2025)

NASDAQ IMA
$5.04 +0.03 (+0.60%)
As of: Sep 10, 2026 · 3:22 PM EDT
Reported Financials

ImageneBio Quarterly Ratios

Periods 24 quarters
Latest Dec 2025

ImageneBio ratios data for the quarter ended Dec 2025. These financial ratios cover 24 quarters of results from Mar 2020 through Dec 2025, standardized by Business Quant from the company’s SEC filings.

Ratios Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Profitability
EBT Margin
-279.79%-357.31%-387.48%13.83%-497.61%-5,376.44%-270.82%-258.66%-267.63%-854.04%-1,463.54%-2,981.94%-90.94%-759.63%
EBIT Margin
-279.79%-357.48%-387.67%13.81%-501.24%-5,484.55%-279.23%-277.32%-292.02%-922.65%-1,645.82%-3,324.43%-58.17%-749.38%
EBITDA Margin
-279.79%-357.48%-387.67%13.81%-501.24%-5,484.55%-279.23%-277.32%-292.02%-922.65%-1,645.82%-3,324.43%-58.17%-749.38%
Operating Margin
-279.79%-357.48%-387.67%13.81%-501.24%-5,484.55%-279.23%-277.32%-292.02%-922.65%-1,645.82%-3,324.43%-58.17%-749.38%
Net Margin
-279.79%-357.31%-387.48%13.83%-497.61%-5,376.44%-270.82%-258.66%-267.63%-854.04%-1,463.54%-2,981.94%-176.60%-1,141.00%
FCF Margin
-403.25%-448.32%-485.16%-68.84%-585.61%-5,330.10%-272.98%-328.18%-375.23%-905.34%-1,687.51%-3,350.68%370.34%-903.75%
Efficiency
Assets AverageAssets Avg.
231.03M286.24M270.27M254.79M237.81M219.47M200.83M181.36M162.33M162.08M193.55M203.71M182.44M165.13M153.24M82.45M73.38M128.50M143.52M156.93M
Invested CapitalInvested Cap.
156.20M-125.16M-152.00M139.83M
Asset Utilization RatioAsset Util.
0.040.030.040.120.130.130.150.090.110.120.070.040.050.080.040.03
Leverage & Solvency
Interest Coverage RatioInterest Cover
-346.16-445.77-0.00M0.01M-0.00M-0.01M-0.00M
Debt Ratio
0.000.000.54
Times Interest Earned
-346.16-445.77-0.00M0.01M-0.00M-0.01M-0.00M
Valuation
Price to EarningsP/E
-11.19-39.70-31.19125.45-13.08-7.82-7.42-6.84-8.80-16.21-11.01-4.84-3.61-4.79-13.51-4.53-6.77-6.02-2.71
Price to SalesP/S
31.31141.85120.8617.3665.09420.3920.1017.7023.54138.46161.15144.2623.8577.21
Price to BookP/B
0.482.332.231.691.140.920.810.660.931.771.23-0.75-0.50-0.54-0.55-0.49-0.36-0.360.500.44
Enterprise Value
-172.24M239.44M206.86M118.68M7.88M-32.22M-45.65M-60.51M-12.73M120.16M-5.97M-80.40M-88.83M-65.80M-54.55M141.07M-52.28M-30.98M-73.09M-76.51M
EV to EBIT
17.72-18.87-14.2442.51-0.461.542.554.000.82-6.500.313.674.874.1626.79-5.028.724.212.75
EV to EBITDA
17.72-18.87-14.2442.51-0.461.542.554.000.82-6.500.313.674.874.1626.79-5.028.724.212.75
Market Capitalization
108.77M503.44M452.76M350.90M220.26M160.59M128.71M96.44M125.08M277.47M190.97M95.06M68.52M79.62M83.48M79.14M61.77M64.66M69.49M58.83M
Price to FCFP/FCF
-7.76-31.64-24.91-25.21-11.11-7.89-7.36-5.39-6.27-15.29-9.55-4.31-3.74-6.376.44-2.81-8.54-5.43-3.23
EV to FCF
12.30-15.05-11.38-8.53-0.401.582.613.380.64-6.620.303.644.855.26-4.21-5.017.232.603.40
EV to CFO
13.08-15.23-11.50-8.88-0.401.662.653.430.64-6.620.303.684.855.26-4.21-5.017.232.603.40
Return Ratios
Return on Sales [ROS]ROS
-279.79%-357.48%-387.67%13.81%-501.24%-5,484.55%-279.23%-277.32%-292.02%-922.65%-1,645.82%-3,324.43%-58.17%-749.38%-877.27%-1,582.84%
Return on Capital Employed [ROCE]ROCE
-23.41%-21.39%-26.28%-15.00%-19.47%-26.00%-30.15%-44.35%-46.81%-44.64%-39.37%-39.80%-45.35%-48.08%-40.27%-98.40%-80.46%-35.90%-51.41%
Return on Assets [ROA]ROA
-20.37%-19.10%-23.30%-13.39%-17.34%-22.37%-25.85%-37.94%-40.78%-38.73%-32.43%-33.54%-38.51%-40.49%-34.40%-61.29%-55.19%-26.74%-38.97%